On Wednesday, August 7, Affimed AFMD will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Earnings and Revenue
Analysts are expecting Affimed to report a loss of 14 cents per share. Revenue will likely be around $3.97 million, according to the consensus estimate.
In the same quarter last year, Affimed reported a loss per share of 15 cents on sales of $0.17 million. Revenue would be up 2181.61% from the same quarter last year. In comparison to analyst estimates in the past, here's how the company's reported EPS stacks up:
| Quarter | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 |
| EPS Estimate | -0.170 | -0.18 | -0.17 | -0.18 | -0.18 |
| EPS Actual | 0.030 | 0.17 | -0.22 | -0.15 | -0.18 |
Stock Performance
Over the last 52-week period, shares are up 63.03%. Given that these returns are generally positive, long-term shareholders are probably content going into this earnings release. Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. The popular rating by analysts on Affimed stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
Affimed is scheduled to hold a conference call at 8:30 a.m. ET and can be accessed here: https://edge.media-server.com/mmc/p/mrrvcw92
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
